Search for: "PFIZER" Results 1521 - 1540 of 4,632
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Mar 2017, 1:49 am by Mark Summerfield
  Unfortunately for Pfizer, Justice Stephen Burley has denied its application for discovery, ruling its evidence insufficient to establish a ‘reasonable belief’, as opposed to a ‘mere suspicion’, that SBA is infringing its patents relating to a process for producing etanercept: Pfizer Ireland Pharmaceuticals v Samsung Bioepis AU Pty Ltd [2017] FCA 285. [read post]
4 Jan 2010, 7:04 pm by Dr. Shezad Malik
Pfizer does not agree that studies have shown that the drugs cause breast cancer. [read post]
28 Jan 2016, 9:02 am by Gene Pierson
Patent Term Adjustment (PTA) is utilized by the Patent Office so that an inventor’s patent protection is not limited by delays caused by the Patent Office. [read post]
7 Feb 2014, 6:04 am by Lawrence B. Ebert
Relating to the drug Lyrica, the CAFc decision has some interesting statements about enablement and written description in the context of covering enantiomers from racemates. [read post]
1 Apr 2007, 7:39 am
The world's largest drug maker, Pfizer Inc., submitted pregabalin to the Food and Drug Administration in October. [read post]
14 Feb 2013, 4:28 pm by Madhulika Vishwanathan
” The decision of the controller can be accessed here .Sunitinib, 50 mg tablet strength is marketed by Pfizer at an exorbitant price of Rs. 61,000 for a strip of seven tablets. [read post]
5 May 2021, 12:56 pm by Dennis Crouch
Thus,  the TRIPS dispute resolution process does not provide Pfizer standing to sue India for violating IP rights guaranteed under TRIPS; Rather Pfizer could only lobby to the U.S. [read post]
30 Mar 2012, 6:15 pm by Patent Docs
Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff; Jonathan Singer of Fish & Richardson, who has represented the Mayo Clinic in its patent litigation with Prometheus; and Bryan Zielinski, Vice President, Assistant General Counsel, and Head of Pfizer's Business Unit IP group, will examine ways forward after the Mayo decision. [read post]
6 Apr 2014, 10:58 pm by Lawrence B. Ebert
Within The biggest threat to patent reform: The Apple/IBM/Microsoft coalition , we seem to have an argument that the coalition of Apple, DuPont, Ford, GE, IBM, Microsoft, and Pfizer, etc. are fighting patent reform so that trolls can prey on high-growth, disruptive, and nimble startups, which are a threat to the established companies.One might think the larger company would simply buy the high-growth, disruptive company and make a product, rather than having a third party troll destroy the… [read post]
18 Jan 2013, 9:55 pm by Patent Docs
A panel consisting of Patricia Carson of Kirkland & Ellis, LLP; Adrian Looney of Pfizer, Inc.; and Eli Loots of Knobbe Martens Olson & Bear, LLP will consider: • What steps patent owners should take in light of recent court decisions such as Exelixis v. [read post]
23 Sep 2013, 3:03 pm by David Lat
., Klein Financial Services, Lawyer Drinking, M&A, Mergers and Acquisitions, Michael Shechtman, Partner Issues, Partners With Issues, Pfizer, Robert M. [read post]
24 Jun 2008, 11:24 pm
As we all know, if the New York Times wrote about something, Pfizer's lawyers can't use it against me in court. [read post]
16 Apr 2023, 9:40 pm by Patent Docs
.; Sharon Reiche of Pfizer Inc.; and Bill Warren of Eversheds Sutherland, who were involved in the preparation of IPO's comments, will cover issues such as trade secret protection, counterfeiting, compulsory licenses, issues in IP enforcement, genetic resources and an overview of developments at multilateral organizations. [read post]
5 May 2014, 5:58 am
.'s Labour party wants inquiry into Pfizer's AstraZeneca bid, ReutersReport notes pressure on Credit Suisse to plead guilty in tax dispute, Reuters [read post]